Masimo Corp. Stock
Price
Target price
€128.75
€128.75
-0.750%
-0.95
-0.750%
€176.30
12.08.25 / Tradegate
WKN: 578074 / Symbol: MASI / Name: Masimo / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Masimo Corp. Stock
The price for the Masimo Corp. stock decreased slightly today. Compared to yesterday there is a change of -€0.950 (-0.750%).
With 17 Buy predictions and not the single Sell prediction the community is currently very high on Masimo Corp..
With a target price of 176 € there is a positive potential of 36.7% for Masimo Corp. compared to the current price of 128.75 €.
Pros and Cons of Masimo Corp. in the next few years
Pros
?
B****
?
S********** s********
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Masimo Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Masimo Corp. | -0.750% | -7.673% | -7.607% | 10.137% | -21.518% | -14.423% | -28.472% |
| Haemonetics Corp. | -1.800% | -31.692% | -30.625% | -34.706% | -41.192% | -36.571% | -33.731% |
| Neogen Corp. | 1.360% | 10.345% | 5.164% | -70.331% | -62.667% | - | - |
| Merit Medical Systems | 0.700% | -2.069% | -11.250% | -13.939% | -22.404% | 18.333% | 85.864% |
Comments
Masimo Corporation (NASDAQ: MASI) had its price target raised by analysts at Piper Sandler from $200.00 to $210.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for MASI provided by MarketBeat
Masimo Corporation (NASDAQ: MASI) had its "buy" rating re-affirmed by analysts at BTIG Research.
Show more
Ratings data for MASI provided by MarketBeat
Masimo Co. (NASDAQ: MASI) had its price target lowered by analysts at Raymond James from $204.00 to $185.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for MASI provided by MarketBeat
News
Masimo Tops EPS, Revenue Expectations
Masimo (NASDAQ:MASI), a provider of noninvasive patient monitoring technology, released its fourth-quarter earnings for 2024, on Feb. 25, 2025. The results presented a mixed picture: strong
